Eli Lilly Says Michigan AG's Insulin Pricing Probe Is Baseless

Michigan Attorney General Dana Nessel's case for investigating Eli Lilly's insulin prices is based on fundamentally flawed premises, such as comparing what consumers pay in Michigan to Canada, the drugmaker has...

Already a subscriber? Click here to view full article